← Back to Search

Other

Lu AG06466 for Post-Traumatic Stress Disorder

Phase 1
Waitlist Available
Research Sponsored by H. Lundbeck A/S
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 12-13
Awards & highlights

Study Summary

This trial will study the effects of a new drug, Lu AG06466, on people with PTSD. The drug will be given in doses of 30mg.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 12-13
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 12-13 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Behavioural Measures During fMRI Tasks
Behavioural Measures During the Threat Processing Task
Functional Magnetic Resonance Imaging (fMRI) Data: Mean Blood Oxygen Level Dependent (BOLD) Percent Signal Change During Card Guessing Task
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Lu AG06466Experimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lu AG06466
2020
Completed Phase 1
~90

Find a Location

Who is running the clinical trial?

H. Lundbeck A/SLead Sponsor
325 Previous Clinical Trials
77,548 Total Patients Enrolled
Email contact via H. Lundbeck A/SStudy DirectorLundbeckClinicalTrials@Lundbeck.com
188 Previous Clinical Trials
58,305 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants is the trial aiming to recruit?

"Affirmative. According to clinicaltrials.gov, this medical research is still recruiting participants after being initially published on September 30th 2020 and last updated June 15th 2022. The project requires the recruitment of 30 individuals from two distinct locations."

Answered by AI

Is participation in this research project possible?

"This clinical trial requires the enrolment of 30 individuals between 18 and 55 years old with a confirmed diagnosis of post traumatic stress disorder. For eligibility, they must also have an elevated Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) score, alterations in arousal/reactivity as reported on CAPS-5, ongoing sleep disturbances based on CAPS-5 assessment, willingness to abstain from prohibited medications during the study period and completion of a psychotropic medication washout phase. Additionally participants cannot have any contraventions that would preclude MRI scans."

Answered by AI

Is this research project accommodating participants who are younger than 45?

"The eligibility requirements for this study stipulate that the minimum age to participate is 18 and no patient can be over 55 years old."

Answered by AI

Are there any vacancies available in this clinical experiment?

"Affirmative, the information hosted on clinicaltrials.gov demonstrates that this experiment is currently recruiting participants. It was first revealed to the public on September 30th 2020 and its most recent edition occurred June 15th 2022. This investigation requires a total of 30 volunteers from two sites."

Answered by AI

Has the Food and Drug Administration certified Lu AG06466 as safe for use?

"Since this is the first phase of testing, data on Lu AG06466's efficacy and safety are limited. Thus, our team at Power has graded its safety as a 1."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
Oregon
California
How old are they?
18 - 65
What site did they apply to?
Collaborative Neuroscience Network
Collaborative NeuroScience Network LLC
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
~8 spots leftby Apr 2025